Top Markets
Coin of the day
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Clasificación en acciones #27070
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Precio por acción
$2.04
Última sincronización: 2025-12-09
Capitalización bursátil
$35.38M
Cambio (1 día)
0.00%
Cambio (1 año)
-2.39%
País
IE
Comercio Mural Oncology plc (MURA)

Categoría

Historial del precio de la acción de Mural Oncology plc (MURA)
Precio más alto de cierre: $2.04 el 2025-12-01

Precio más bajo de cierre: $3.85 el 2023-11-01
Historial del precio de la acción de Mural Oncology plc desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 1.79%
2025 -42.95%
2024 -13.07%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$760.05 6.79%
CH